Aspire Biopharma Stock Technical Analysis
| ASBP Stock | 1.32 0.23 14.84% |
As of the 5th of February, Aspire BioPharma shows the Risk Adjusted Performance of (0.15), standard deviation of 12.45, and Mean Deviation of 8.33. Aspire BioPharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Aspire BioPharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Aspire, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AspireAspire BioPharma's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Can Pharmaceuticals industry sustain growth momentum? Does Aspire have expansion opportunities? Factors like these will boost the valuation of Aspire BioPharma. If investors know Aspire will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Aspire BioPharma demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Aspire BioPharma's market price often diverges from its book value, the accounting figure shown on Aspire's balance sheet. Smart investors calculate Aspire BioPharma's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Since Aspire BioPharma's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Aspire BioPharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aspire BioPharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Aspire BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Aspire BioPharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aspire BioPharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aspire BioPharma.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in Aspire BioPharma on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Aspire BioPharma or generate 0.0% return on investment in Aspire BioPharma over 90 days. Aspire BioPharma is related to or competes with AleAnna. Aspire BioPharma is entity of United States More
Aspire BioPharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aspire BioPharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aspire BioPharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.22) | |||
| Maximum Drawdown | 66.08 | |||
| Value At Risk | (23.85) | |||
| Potential Upside | 19.52 |
Aspire BioPharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aspire BioPharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aspire BioPharma's standard deviation. In reality, there are many statistical measures that can use Aspire BioPharma historical prices to predict the future Aspire BioPharma's volatility.| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (2.53) | |||
| Total Risk Alpha | (3.56) | |||
| Treynor Ratio | 1.28 |
Aspire BioPharma February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.15) | |||
| Market Risk Adjusted Performance | 1.29 | |||
| Mean Deviation | 8.33 | |||
| Coefficient Of Variation | (473.88) | |||
| Standard Deviation | 12.45 | |||
| Variance | 155.06 | |||
| Information Ratio | (0.22) | |||
| Jensen Alpha | (2.53) | |||
| Total Risk Alpha | (3.56) | |||
| Treynor Ratio | 1.28 | |||
| Maximum Drawdown | 66.08 | |||
| Value At Risk | (23.85) | |||
| Potential Upside | 19.52 | |||
| Skewness | 0.8929 | |||
| Kurtosis | 3.85 |
Aspire BioPharma Backtested Returns
Aspire BioPharma secures Sharpe Ratio (or Efficiency) of -0.17, which signifies that the company had a -0.17 % return per unit of risk over the last 3 months. Aspire BioPharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aspire BioPharma's Standard Deviation of 12.45, mean deviation of 8.33, and Risk Adjusted Performance of (0.15) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -2.06, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Aspire BioPharma are expected to decrease by larger amounts. On the other hand, during market turmoil, Aspire BioPharma is expected to outperform it. At this point, Aspire BioPharma has a negative expected return of -2.21%. Please make sure to confirm Aspire BioPharma's information ratio, potential upside, as well as the relationship between the Potential Upside and rate of daily change , to decide if Aspire BioPharma performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.22 |
Weak predictability
Aspire BioPharma has weak predictability. Overlapping area represents the amount of predictability between Aspire BioPharma time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aspire BioPharma price movement. The serial correlation of 0.22 indicates that over 22.0% of current Aspire BioPharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.22 | |
| Spearman Rank Test | 0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 1.93 |
Aspire BioPharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Aspire BioPharma Technical Analysis
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Aspire BioPharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Aspire BioPharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Aspire BioPharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Aspire BioPharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Aspire BioPharma price pattern first instead of the macroeconomic environment surrounding Aspire BioPharma. By analyzing Aspire BioPharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Aspire BioPharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Aspire BioPharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Aspire BioPharma February 5, 2026 Technical Indicators
Most technical analysis of Aspire help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Aspire from various momentum indicators to cycle indicators. When you analyze Aspire charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.15) | |||
| Market Risk Adjusted Performance | 1.29 | |||
| Mean Deviation | 8.33 | |||
| Coefficient Of Variation | (473.88) | |||
| Standard Deviation | 12.45 | |||
| Variance | 155.06 | |||
| Information Ratio | (0.22) | |||
| Jensen Alpha | (2.53) | |||
| Total Risk Alpha | (3.56) | |||
| Treynor Ratio | 1.28 | |||
| Maximum Drawdown | 66.08 | |||
| Value At Risk | (23.85) | |||
| Potential Upside | 19.52 | |||
| Skewness | 0.8929 | |||
| Kurtosis | 3.85 |
Aspire BioPharma February 5, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Aspire stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 72,616 | ||
| Daily Balance Of Power | (0.82) | ||
| Rate Of Daily Change | 0.85 | ||
| Day Median Price | 1.40 | ||
| Day Typical Price | 1.37 | ||
| Price Action Indicator | (0.19) |
Additional Tools for Aspire Stock Analysis
When running Aspire BioPharma's price analysis, check to measure Aspire BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspire BioPharma is operating at the current time. Most of Aspire BioPharma's value examination focuses on studying past and present price action to predict the probability of Aspire BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspire BioPharma's price. Additionally, you may evaluate how the addition of Aspire BioPharma to your portfolios can decrease your overall portfolio volatility.